Partners' Directory

  Home   Search   Join the Partnership   Login

Contact General Specializations in Countries Contribution to the Global Plan Declaration

View this partner's profile

Organization Contact Information

Name: Massachusetts Supranational TB Reference Laboratory
Street 1: University of Massachusetts Medical School
Street 2: 305 South Street
City: Jamaica Plain
Province: MA
Post Code: 02130
Country: United States of America
Phone: 508.856.3646
Organization Email: martin.baker@umassmed.edu
Web Site: http://www.msrl-umassmed.org/
Other Online Presence:

Focal Point Contact Information

Salutation: Dr.
First Name: Alexander
Last Name: Sloutsky
Title: Director
Email: alex.sloutsky@umassmed.edu
Phone: 617-983-6370

Alternate Focal Point Contact Information

Salutation: Mr.
First Name: Martin
Last Name: Baker
Title: Director, Reference Laboratory Division
Email: martin.baker@umassmed.edu
Phone: 617-983-6265

General Information

Board Constituency: Technical agencies
Is your organization legally registered in your country: Yes
If yes, please enter your registration number:
Organization Type - Primary: Academic / Research Institution
Organization Type - Secondary: None
Organization Description:
The Massachusetts Supranational TB Reference Laboratory (MSRL) is a World Health Organization (WHO) appointed SRL. Located at the Massachusetts State Department of Public Health Laboratory, the MSRL is managed and operated by the University of Massachusetts Medical School. As a University-based SRL and long-term laboratory collaborator with Partners In Health (PIH), the MSRL develops and participates in research (basic and operational) and is available to provide technical assistance and training support to developing countries. With an emphasis placed upon the role of quality assurance in laboratory infrastructure development, the MSRL is currently engaged in operational projects in Ecuador, Haiti, and Suriname. MSRL has participated in the development of laboratory infrastructure and provision of interim laboratory support services in the following locations: CAREC (Caribbean Epidemiology Center), Dominican Republic, Ecuador, Haiti, Jamaica Lesotho, Peru, Russia (Tomsk), and Vietnam. The lab regularly organizes and conducts training sessions for both domestic and international participants.
 
Do you know about the UNHLM declaration:

Specializations / Areas of Work

Delivery of health services and care
Provision of drugs, diagnostics and commodities
Research and Development
Technical Assistance

Other Organization Information

Total number of staff in your organization: 100 +
Number of full-time staff who are directly involved with TB: 6 - 10
Number of part-time staff who are directly involved with TB: 0
Number of volunteers who are directly involved with TB: 0
 
How did you hear about the Stop TB Partnership: Involvement in TB control provision
If you were informed or referred by another partner of the Stop TB Partnership please tell us who:
Why do you wish join the Stop TB Partnership: Technical assistance and advice
 
Are you a member of a Stop TB national partnership: Peru
Are you in contact with your national TB programme: No
Please tell us how your organization is contributing to your country's national TB control plan:
Technical assistance and diagnosis of drug resistant TB in Massachusetts.
 

Geographical Reach

Which country is your headquarters located in: United States of America
Which countries do you do operate in:
(This includes countries you are conducting activities in)
Dominican Republic
Ecuador
Haiti
Jamaica
Peru
Suriname
Trinidad and Tobago
United States of America

Contribution

Please tell us how your organization will contribute to the Global Plan to Stop TB by briefly describing its involvement in any of the areas of work listed below:

Drug-Resistant TB:
Direct provision of diagnostics to high burden locations with insufficient capacity.

Laboratory Strengthening:
Development of laboratory capacity in developing and middle income countries within the America's Region.

New Diagnostics:
Evaluation and validation of new rapid molecular technologies.

Research:
Development and implementation of surveillance for drug resistance in multiple countries, including Haiti and Ecuador.

Declaration

Declaration of interests:
No conflicts of interest were delacred.

Application date: April 24, 2009
Last updated: May 9, 2012